SAN DIEGO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Shareholder rights law firm Robbins Arroyo LLP announces that a purchaser of electroCore, Inc. (NASDAQ: ECOR) filed a class action complaint for alleged violations of the Securities Exchange Act of 1933 in connection with electroCore's 2018 initial public offering ("IPO"), and violations of the Securities Exchange Act of 1934 between June 22, 2018 and September 25, 2019. ElectroCore is a bioelectronic medicine company with a non-invasive vagus nerve stimulation ("VNS") therapy. Its lead product, gammaCore, is used for acute treatment of pain associated with migraines and episodic cluster headaches in adults.
If you suffered a loss as a result of ElectroCore's misconduct, click here.
ElectroCore, Inc. (ECOR) Accused of Misleading Shareholders
According to the complaint, in June 2018, electroCore held its initial public offering ("IPO") offering 5,980,000 shares of common stock for $15.00 per share and receiving proceeds of approximately $79.5 million. In its Registration Statement, electroCore touted the competitive strengths of its innovative gammaCore product and addressed plans to commercialize the product as a leading headache therapy. However, despite electroCore's representations, gammaCore did not possess competitive advantages for migraine and headache therapy and was unlikely to be adopted by physicians and patients over existing treatments. After multiple statements of disappointing financial results, on September 25, 2019, electroCore revealed that the U.S. Food and Drug Administration requested more information before approving electroCore's submission for the use of gammaCore. On this news, electroCore's share price fell 23% to close at $2.57, an almost 83% decline from its IPO price. The stock has yet to recover.
If you purchased electroCore, Inc. (ECOR) securities between June 22, 2018 and September 25, 2019, you have until November 25, 2019, to ask the court to be appointed lead plaintiff for the class.
Robbins Arroyo LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.
Attorney Advertising. Past results do not guarantee a similar outcome.